OBLG Oblong, Inc. Insider Trading

Holst (CEO) buys 5,000 OBLG shares at $1.90; stock now at $1.85, -65.2% from 52-week high; company unprofitable with -37.6% revenue decline.

Holst, President and CEO, purchased 5,000 shares for $9,500 on 2025-11-19 at $1.90, increasing his holdings by 47.4% to 15,544 shares—a substantial percentage increase by a company officer. However, the context is concerning: the stock is currently trading at $1.85, down 39.3% over 30 days and 39.1% over 90 days, and down 65.2% from its 52-week high of $5.32. The company faces significant headwinds with annual revenue declining 37.6% and net income at negative $2,290,000 on quarterly revenue of just $601,000. This buy follows a prior OBLG purchase by Holst on 2025-11-14, suggesting accumulation during a sharp downturn, though the timing against the company's deteriorating fundamentals and ongoing stock decline offers limited reassurance about the transaction's wisdom.

CEO Holst purchases 10,000 shares ($18.4K) amid -37.6% revenue decline and -$2.3M annual loss; stock down -65.0% YTD

Holst Peter, President and CEO of Oblong, Inc., purchased 10,000 shares at $1.84 on 2025-11-14, increasing his holdings from 544 to 10,544 shares. The transaction occurred while the company faces significant operational headwinds: annual revenue declined -37.6% year-over-year, the company posted a net loss of -$2.3M on quarterly revenue of $601.0K, and the stock has fallen -65.0% from its 52-week high. The share purchase represents a material shift in his ownership stake (+1838.2% vs pre-transaction holdings), but the timing coincides with a period of acute financial deterioration and depressed valuation. At current price of $1.86 (near the 52-week low), the market's confidence in the company's near-term trajectory remains under pressure.

Director Jonathan Schechter buys 10,000 shares of OBLG at $1.91; stock down 65.0% from 52-week high amid revenue decline and persistent losses.

Jonathan Schechter, a director of Oblong, Inc., purchased 10,000 shares (increasing his holdings by 66.7% to 25,000 shares total) at $1.91 on 2025-11-14 while the stock trades at $1.86, down 65.0% from its 52-week high and off 34.3% over 30 days. The company's fundamentals show severe strain: revenue declined 37.6% year-over-year to $601.0K in the latest quarter, the firm posted a net loss of $2.3M and remains unprofitable on a full-year basis, with a market cap of only $6.0M. Schechter's two prior purchases at this ticker posted a 5.0% 30-day return and a -2.6% 30-day return respectively, neither yet measurable at 90 days. His cross-ticker track record averaged +1.2% returns over 30 days on 2 buys, with no prior trades well-timed at the 90-day mark, and no timing pattern established. The purchase reflects activity by a single insider in a distressed-stage microcap with deteriorating revenue and ongoing losses.

Director Jonathan Schechter buys 5,000 OBLG shares at $2.70; stock down 58.9% from 52-week high, company unprofitable with -37.6% revenue decline

Jonathan Schechter purchased 5,000 shares at $2.70 on 2025-09-17, increasing his holdings from 10,000 to 15,000 shares. This purchase occurred as the stock trades 58.9% below its 52-week high of $6.54 and reflects a 30-day decline of -21.1%. The company faces significant headwinds: Oblong reported $592,000 in quarterly revenue with a $-605,000 net loss, alongside an annual revenue decline of -37.6% versus the prior year, leaving the company unprofitable. Schechter made a similar purchase the prior trading day (2025-09-16), suggesting back-to-back accumulation at depressed levels. However, his prior open-market trade history (1 prior cross-ticker buy) does not yet establish a pattern of well-timed acquisitions, and the lack of measurable outcomes from prior same-ticker trades limits the signal strength of this activity.

Director SCHECHTER JONATHAN buys 10,000 shares (10.0K) of OBLG at $2.73; stock down 40.1% in 90 days, -37.6% revenue growth YoY.

SCHECHTER JONATHAN purchased 10,000 shares at $2.73 on 2025-09-16 with zero prior holdings, establishing a new position. The timing occurs against a backdrop of significant deterioration: the stock has declined 40.1% over the past 90 days and trades 63.5% below its 52-week high of $6.54, while the company reported annual revenue growth of -37.6% and net income of $-605,000.00 in its latest quarter. The company's market cap of $5,617,233.73 reflects a micro-cap with negative profitability and declining top-line momentum. This purchase represents the director's first accumulation in the stock and occurs during a pronounced downtrend, though the FACTS section provides no information about the director's prior transaction history, strategic rationale, or acquisition plans that would clarify whether this reflects opportunistic entry or signaling of underlying value recognition.

Director Jason T Adelman purchases 10,000 shares of OBLG for $26,631.70 across 5 transactions on 2025-09-04

Director Jason T Adelman purchased 10,000 shares across 5 separate transactions totaling $26,631.70 on 2025-09-04, establishing an initial position at a blended average price of $2.66 against a current price of $2.82. The purchase occurs as OBLG trades 56.9% below its 52-week high of $6.54 and has declined 30.2% over the past 90 days, alongside deteriorating fundamentals: the company reported a net loss of $-605,000.00 in the latest quarter, annual revenue contracted 37.6% year-over-year, and the business has been unprofitable over its most recent full fiscal year. While Adelman's cross-ticker track record shows 100% win rate across prior buys, this metric reflects outcomes on different securities and does not establish predictive value for OBLG specifically; the transaction represents an entry into a micro-cap ($6.6M market cap) company in material financial distress.